What is Axtria?
Founded in 2010 by Jassi Chadha, Axtria provides a comprehensive suite of data-driven solutions tailored for the life sciences industry. The company specializes in managing the massive influx of data generated by modern healthcare digitization, offering enterprise-grade analytics that integrate seamlessly into existing customer ecosystems. By focusing on product commercialization, Axtria helps organizations optimize sales performance and improve patient outcomes through advanced cloud technology. Its market position is defined by its ability to bridge the gap between complex data sets and actionable business intelligence, serving as a vital partner for global pharmaceutical and biotech firms.
How much funding has Axtria raised?
Axtria has raised a total of $377.8M across 10 funding rounds:
Private Equity
$4.3M
Series A
$2.5M
Private Equity
$4.8M
Private Equity
$5.6M
Multiple Rounds
$55.6M
Debt
$5M
Private Equity
$150M
Private Equity
$150M
Private Equity (2009): $4.3M, investors not publicly disclosed
Series A (2010): $2.5M led by Sequoia Capital India
Private Equity (2013): $4.8M, investors not publicly disclosed
Private Equity (2014): $5.6M, investors not publicly disclosed
Series B (2015): $5.6M, investors not publicly disclosed
Private Equity (2015): $20M, investors not publicly disclosed
Series C (2015): $30M led by Helion Ventures
Debt (2020): $5M supported by PPP
Private Equity (2021): $150M featuring Bain Capital Tech Opportunities
Private Equity (2021): $150M backed by Bain Capital Tech Opportunities
Key Investors in Axtria
Sequoia Capital India
A premier venture capital firm with a global footprint, specializing in early-stage and growth-stage investments across technology and consumer sectors.
Helion Ventures
A multi-stage, India-focused venture fund that supports technology-powered businesses and consumer services with significant capital and operational expertise.
Bain Capital Tech Opportunities
A specialized investment arm of Bain Capital focused on high-growth technology companies, providing strategic capital to scale enterprise software and digital infrastructure.
What's next for Axtria?
With the support of its latest capital injection, Axtria is poised to accelerate its product innovation roadmap and deepen its market penetration. The strategic focus will likely center on enhancing its AI-driven analytics capabilities and expanding its global service delivery model to meet the evolving demands of the life sciences sector. As the industry continues to prioritize data-centric decision-making, Axtria is well-positioned to capitalize on the increasing reliance on cloud-based infrastructure, further cementing its status as an essential utility for commercial excellence in healthcare.
See full Axtria company page
